<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">07938</article-id><article-id pub-id-type="doi">10.7554/eLife.07938</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group></article-categories><title-group><article-title>Cross-talk between PRMT1-mediated methylation and ubiquitylation on RBM15 controls RNA splicing</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-32871"><name><surname>Zhang</surname><given-names>Li</given-names></name><aff><institution content-type="dept">Department of Biochemistry and Molecular Genetics, UAB Stem Cell Institute</institution>, <institution>The University of Alabama at Birmingham</institution>, <addr-line><named-content content-type="city">Birmingham</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-32870"><name><surname>Tran</surname><given-names>Ngoc-Tung</given-names></name><aff><institution content-type="dept">Department of Biochemistry and Molecular Genetics, UAB Stem Cell Institute</institution>, <institution>The University of Alabama at Birmingham</institution>, <addr-line><named-content content-type="city">Birmingham</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-32872"><name><surname>Su</surname><given-names>Hairui</given-names></name><aff><institution content-type="dept">Department of Biochemistry and Molecular Genetics, UAB Stem Cell Institute</institution>, <institution>The University of Alabama at Birmingham</institution>, <addr-line><named-content content-type="city">Birmingham</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-32873"><name><surname>Wang</surname><given-names>Rui</given-names></name><aff><institution content-type="dept">Program of Molecular Pharmacology, Sloan Kettering Institute</institution>, <institution>Memorial Sloan Kettering Cancer Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-32874"><name><surname>Lu</surname><given-names>Yuheng</given-names></name><aff><institution content-type="dept">Computational Biology Program, Sloan Kettering Institute</institution>, <institution>Memorial Sloan Kettering Cancer Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-32875"><name><surname>Tang</surname><given-names>Haiping</given-names></name><aff><institution content-type="dept">School of Life Sciences</institution>, <institution>Tsinghua University</institution>, <addr-line><named-content content-type="city">Beijing</named-content></addr-line>, <country>China</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-43608"><name><surname>Aoyagi</surname><given-names>Sayura</given-names></name><aff><institution>Cell Signaling Technology, Inc.</institution>, <addr-line><named-content content-type="city">Danvers</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-32876"><name><surname>Guo</surname><given-names>Ailan</given-names></name><aff><institution>Cell Signaling Technology, Inc.</institution>, <addr-line><named-content content-type="city">Danvers</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-32877"><name><surname>Khodadadi-Jamayran</surname><given-names>Alireza</given-names></name><aff><institution content-type="dept">Department of Biochemistry and Molecular Genetics, UAB Stem Cell Institute</institution>, <institution>The University of Alabama at Birmingham</institution>, <addr-line><named-content content-type="city">Birmingham</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-32878"><name><surname>Zhou</surname><given-names>Dewang</given-names></name><aff><institution content-type="dept">Department of Biochemistry and Molecular Genetics, UAB Stem Cell Institute</institution>, <institution>The University of Alabama at Birmingham</institution>, <addr-line><named-content content-type="city">Birmingham</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-32879"><name><surname>Qian</surname><given-names>Kun</given-names></name><aff><institution content-type="dept">Department of Pharmaceutical and Biomedical Sciences</institution>, <institution>The University of Georgia</institution>, <addr-line><named-content content-type="city">Athens</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-32880"><name><surname>Hricik</surname><given-names>Todd</given-names></name><aff><institution content-type="dept">Human Oncology and Pathogenesis Program, Sloan Kettering Institute</institution>, <institution>Memorial Sloan Kettering Cancer Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-32881"><name><surname>Côté</surname><given-names>Jocelyn</given-names></name><aff><institution content-type="dept">Department of Cellular and Molecular Medicine</institution>, <institution>University of Ottawa</institution>, <addr-line><named-content content-type="city">Ottawa</named-content></addr-line>, <country>Canada</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-32882"><name><surname>Han</surname><given-names>Xiaosi</given-names></name><aff><institution content-type="dept">Department of Neurology, Comprehensive Cancer Center</institution>, <institution>The University of Alabama at Birmingham</institution>, <addr-line><named-content content-type="city">Birmingham</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-32883"><name><surname>zhou</surname><given-names>Wenping</given-names></name><aff><institution content-type="dept">Department of Internal Medicine</institution>, <institution>Zhengzhou - Henan Cancer Hospital</institution>, <addr-line><named-content content-type="city">Zhengzhou</named-content></addr-line>, <country>China</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-32884"><name><surname>Laha</surname><given-names>Suparna</given-names></name><aff><institution content-type="dept">Division of Hematology and Oncology</institution>, <institution>University of Massachusetts Medical School</institution>, <addr-line><named-content content-type="city">Worcester</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-32885"><name><surname>Abdel-Wahab</surname><given-names>Omar</given-names></name><aff><institution content-type="dept">Human Oncology and Pathogenesis Program, Sloan Kettering Institute</institution>, <institution>Memorial Sloan Kettering Cancer Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-5101"><name><surname>Levine</surname><given-names>Ross L</given-names></name><aff><institution content-type="dept">Human Oncology and Pathogenesis Program, Sloan Kettering Institute</institution>, <institution>Memorial Sloan Kettering Cancer Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-32886"><name><surname>Raffel</surname><given-names>Glen</given-names></name><aff><institution content-type="dept">Division of Hematology and Oncology</institution>, <institution>University of Massachusetts Medical School</institution>, <addr-line><named-content content-type="city">Worcester</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-32887"><name><surname>Liu</surname><given-names>Yanyan</given-names></name><aff><institution content-type="dept">Department of Internal Medicine</institution>, <institution>Zhengzhou - Henan Cancer Hospital</institution>, <addr-line><named-content content-type="city">Zhengzhou</named-content></addr-line>, <country>China</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-32888"><name><surname>Chen</surname><given-names>Dongquan</given-names></name><aff><institution content-type="dept">Division of Preventive Medicine</institution>, <institution>The University of Alabama at Birmingham</institution>, <addr-line><named-content content-type="city">Birmingham</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-32889"><name><surname>Li</surname><given-names>Haitao</given-names></name><aff><institution content-type="dept">School of Life Sciences</institution>, <institution>Tsinghua University</institution>, <addr-line><named-content content-type="city">Beijing</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-32890"><name><surname>Townes</surname><given-names>Tim</given-names></name><aff><institution content-type="dept">Department of Biochemistry and Molecular Genetics</institution>, <institution>The University of Alabama at Birmingham</institution>, <addr-line><named-content content-type="city">Birmingham</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-32891"><name><surname>Wang</surname><given-names>Hengbin</given-names></name><aff><institution content-type="dept">Department of Biochemistry and Molecular Genetics</institution>, <institution>The University of Alabama at Birmingham</institution>, <addr-line><named-content content-type="city">Birmingham</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-32892"><name><surname>Deng</surname><given-names>Haiteng</given-names></name><aff><institution content-type="dept">School of Life Sciences</institution>, <institution>Tsinghua University</institution>, <addr-line><named-content content-type="city">Beijing</named-content></addr-line>, <country>China</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-32893"><name><surname>Zheng</surname><given-names>Yujun George</given-names></name><aff><institution content-type="dept">Department of Pharmaceutical and Biomedical Sciences</institution>, <institution>The University of Georgia</institution>, <addr-line><named-content content-type="city">Athens</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-23282"><name><surname>Leslie</surname><given-names>Christina</given-names></name><aff><institution content-type="dept">Computational Biology Program, Sloan Kettering Institute,</institution>, <institution>Memorial Sloan Kettering Cancer Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-22651"><name><surname>Luo</surname><given-names>Minkui</given-names></name><aff><institution content-type="dept">Program of Molecular Pharmacology, Sloan Kettering Institute</institution>, <institution>Memorial Sloan Kettering Cancer Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-31923"><name><surname>Zhao</surname><given-names>Xinyang</given-names></name><aff><institution content-type="dept">Department of Biochemistry and Molecular Genetics, UAB Stem Cell Institute</institution>, <institution>The University of Alabama at Birmingham</institution>, <addr-line><named-content content-type="city">Birmingham</named-content></addr-line>, <country>United States</country><email>zhaox88@uab.edu</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1519"><name><surname>Green</surname><given-names>Michael R</given-names></name><role>Reviewing editor</role><aff><institution>Howard Hughes Medical Institute, University of Massachusetts Medical School</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>17</day><month>11</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e07938</elocation-id><supplementary-material><ext-link xlink:href="elife-07938-supp-v2.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>04</day><month>04</month><year>2015</year></date><date date-type="accepted"><day>16</day><month>11</month><year>2015</year></date></history><permissions><copyright-statement>© 2015, Zhang et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Zhang et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>RBM15, an RNA binding protein, determines cell-fate specification of many tissues including blood. We demonstrate that RBM15 is methylated by protein arginine methyltransferase 1 (PRMT1) at residue R578 leading to its degradation via ubiquitylation by an E3 ligase (CNOT4). Overexpression of PRMT1 in acute megakaryocytic leukemia cell lines blocks megakaryocyte terminal differentiation by downregulation of RBM15 protein level. Restoring RBM15 protein level rescues megakaryocyte terminal differentiation blocked by PRMT1 overexpression. At the molecular level, RBM15 binds to pre-mRNA intronic regions of genes important for megakaryopoiesis such as GATA1, RUNX1, TAL1 and c-MPL. Furthermore, preferential binding of RBM15 to specific intronic regions recruits the splicing factor SF3B1 to the same sites for alternative splicing. Therefore, PRMT1 regulates alternative RNA splicing via reducing RBM15 protein concentration. Targeting PRMT1 may be a curative therapy to restore megakaryocyte differentiation for acute megakaryocytic leukemia.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></back></article>